Evidence map›Paper›PMID 18638456›Full record

ArticleBiochemical and biophysical research communications2008

AMPK represses TOP mRNA translation but not global protein synthesis in liver.

Ali K Reiter, Douglas R Bolster, Stephen J Crozier, Scot R Kimball, Leonard S Jefferson

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Sertraline treatment prevents motor dysfunction in a Huntington's disease mouse model and functional decline in patients.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ali K ReiterDepartment of Cellular and Molecular Physiology, The Pennsylvania State College of Medicine, PO Box 850, Hershey, PA 17033, USA.
Douglas R Bolster
Stephen J Crozier
Scot R Kimball
Leonard S Jefferson
Hershey (United States) · US

Funding

REGULATION OF LIVER GROWTH AND FUNCTIONR01DK013499 · NIDDK · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KIMBALL, SCOT R · 1995 to 2018
$8.0M
RESEARCH TRAINING IN PHYSIOLOGICAL ADAPTATION TO STRESST32GM008619 · NIGMS · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI JEFFERSON, LEONARD S · 1996 to 2005
$976k
REGULATION OF LIVER GROWTH AND FUNCTIONR37DK013499 · NIDDK · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI JEFFERSON, LEONARD S · 1986 to 1993
–
NIDDK NIH HHS DK-13499NIDDK NIH HHS R01 DK013499NIGMS NIH HHS GM08619NIGMS NIH HHS T32 GM008619
6 · The paper itself

Abstract

The AMP-activated protein kinase (AMPK) represses signaling through the mammalian target of rapamycin complex 1 (mTORC1). In muscle, repression of mTORC1 leads to a reduction in global protein synthesis. In contrast, repression of mTORC1 in the liver has no immediate effect on global protein synthesis. In the present study, signaling through mTORC1 and translation of specific mRNAs such as those bearing a 5'-terminal oligopyrimidine (TOP) tract and were examined in rat liver following activation of AMPK after treadmill running. Activation of AMPK repressed translation of the TOP mRNAs encoding rpS6, rpS8, and eEF1alpha. In contrast, neither global protein synthesis nor translation of mRNAs encoding GAPDH or beta-actin was changed. Basal phosphorylation of the mTORC1 target 4E-BP1, but not S6K1 or rpS6, was reduced following activation of AMPK. Thus, in liver, AMPK activation repressed translation of TOP mRNAs through a mechanism distinct from downregulated phosphorylation of S6K1 or rpS6.

Indexed as

Protein BiosynthesisActinsAMP-Activated Protein KinasesAnimalsExercise TestGlyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)LiverMaleMultienzyme ComplexesPeptide Elongation Factor 1PhosphorylationPhysical Conditioning, AnimalProtein Serine-Threonine KinasesRatsRats, Sprague-DawleyRibosomal ProteinsActinsAMP-Activated Protein KinasesCrtc1 protein, ratGlyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)Multienzyme ComplexesPeptide Elongation Factor 1Protein Serine-Threonine KinasesRibosomal ProteinsRibosomal Protein S6Ribosomal Protein S6 Kinasesribosomal protein S8RNA, MessengerRps6kb1 protein, ratTranscription Factors

Identifiers

PMID18638456
PMCPMC2533707
OpenAlexW1980692432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.